Last checked at 8 Jun 2023 08:51
FOR RELEASE ON | 08 June 2023 |
IP Group - Life Sciences investor update
IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which invests in breakthrough science and innovation companies with the potential to create a better future for all, announces that it will hold a life sciences investor update on Thursday June 15 2023 featuring Dr Gordon Sanghera, CEO of Oxford Nanopore Technologies plc, and Professor Sir Peter Donnelly, CEO of portfolio company Genomics.
The event will be hosted by CEO Greg Smith and Dr Sam Williams, Managing Partner of Life Sciences at IP Group, and, as announced on 20 April 2023, will be followed by the Group's Annual General Meeting at 11am. Further details of the event and how to register can be found here: bit.ly/3oUjNqb.
The update will also be available remotely through the Investor Meet Company platform. Questions can be submitted in advance of the event via the Investor Meet Company Platform up to 9am the day before the meeting or at any time during the live presentation. Investors can sign up to Investor Meet Company for free via: https://www.investormeetcompany.com/ip-group-plc/register-investor. Investors who already follow IP Group plc on the Investor Meet Company platform will automatically be invited.
No material new information will be released by the Company during the presentation.
For more information, please contact:
IP Group plc | www.ipgroupplc.com |
Liz Vaughan-Adams, Communications | +44 (0) 20 7444 0062/+44 (0) 7967 312125 |
Portland | |
Vic Wallin Alex Donaldson | +44 (0) 7973 823119 +44 (0) 7516 729702 |
Notes for editors
About IP Group
IP Group accelerates the impact of science for a better future. As the most active UK based, early stage science investor, we develop and support some of the world's most exciting businesses in deeptech, life sciences and cleantech (led by Kiko Ventures). Through Parkwalk, the UK's largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, First Light Fusion, Hysata, and Oxa. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.
For more information, please visit our website at www.ipgroupplc.com.
ENDS